Osteoporosis medicine

Preotact® – effective osteoporosis medicine

Preotact® is an osteoporosis medicine that can increase bone density. Preotact® is a full-length parathyroid hormone (PTH) therapy for postmenopausal osteoporosis patients to reduce the risk of bone fracture. Parathyroid hormone that the osteoporosis medicine contains can stimulate bone formation and increase trabecular bone density, which can improve bone microarchitecture and restore bone quality and quantity.

Studies have demonstrated that Preotact® is an osteoporosis medicine that can increase volumetric trabecular bone mineral density in the spine and hip.Patients take Preotact^® as a daily injection. The Preotact™ Pen is specially designed for osteoporosis patients, making it easy for them to inject.

Log in to learn more about osteoporosis medicine

Nycomed

Nycomed is a European pharmaceutical company that has over 20 years’ experience of working with osteoporosis. Nycomed operates throughout Europe and in fast-growing markets in Latin America, Russia/CIS and Asia-Pacific.

Nycomed provides medicines and products for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets. Offering a broad portfolio of products in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management.